5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development
PCS6422
November 1, 2000
Grem JL.
View PublicationStay connected with Necrobiosis Lipoidica study info
Filter By:
A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancer
PCS6422
April 1, 2000
Schilsky RL, Bukowski R, Burris H 3rd, Hochster H, O'Rourke M, Wall JG, Mani S, Bonny T, Levin J, Hohneker J.
View PublicationPhase I and pharmacologic study of oral fluorouracil on a chronic daily schedule in combination with the dihydropyrimidine dehydrogenase inactivator eniluracil
PCS6422
February 1, 2000
Baker SD, Diasio RB, O'Reilly S, Lucas VS, Khor SP, Sartorius SE, Donehower RC, Grochow LB, Spector T, Hohneker JA, Rowinsky EK.
View PublicationMetabolism of lisofylline and pentoxifylline in human liver microsomes and cytosol
Necrobiosis Lipoidica (NL)
November 1, 1996
Lillibridge JA, Kalhorn TF, Slattery JT.
View PublicationIndividualizing therapy with 5-fluorouracil related to dihydropyrimidine dehydrogenase: theory and limits
PCS6422
August 1, 1996
Milano G, Etienne MC.
View PublicationHemorrheologic effects of metabolites of pentoxifylline (Trental)
Necrobiosis Lipoidica (NL)
1995
Ambrus JL, Stadler S, Kulaylat M.
View PublicationRelationship between fluorouracil systemic exposure and tumor response and patient survival.
PCS6422
June 1, 1994
Milano G, Etienne MC, Renée N, Thyss A, Schneider M, Ramaioli A, Demard F.
View Publication5-Ethynyluracil (776C85): a potent modulator of the pharmacokinetics and antitumor efficacy of 5-fluorouracil
PCS6422
December 1, 1993
Baccanari DP, Davis ST, Knick VC, Spector T.
View PublicationDihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy
PCS6422
November 15, 1993
Lu Z, Zhang R, Diasio RB.
View PublicationXanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity
Necrobiosis Lipoidica (NL)
April 1, 1993
Semmler J, Gebert U, Eisenhut T, Moeller J, Schönharting MM, Alléra A, Endres S.
View Publication